Three critical clinicobiological phases of the human SARS-associated coronavirus infections


Turk C., Turk S., Malkan U. Y., Haznedaroglu I. C.

EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, vol.24, no.16, pp.8606-8620, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 24 Issue: 16
  • Publication Date: 2020
  • Doi Number: 10.26355/eurrev_202008_22660
  • Journal Name: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
  • Page Numbers: pp.8606-8620
  • Keywords: Coronavirus, COVID-19, SARS-CoV-2, INNATE IMMUNE-RESPONSES, RECEPTOR, COVID-19, PNEUMONIA, BINDING, CELLS, WUHAN, COV
  • Lokman Hekim University Affiliated: Yes

Abstract

OBJECTIVE: COVID-19 immune syndrome is a multi-systemic disorder induced by the COVID-19 infection. Pathobiological transitions and clinical stages of the COVID-19 syndrome following the attack of SARS-CoV-2 on the human body have not been fully explored. The aim of this review is to outline the three critical prominent phase regarding the clinicogenomics course of the COVID-19 immune syndrome.